Skip to main content
OpenTrials
Completed

NCT Number: NCT02293174

Retinal Fundus Camera Evaluation

Establish a normal baseline setting configuration for image capture using the Topcon TRC-NW400 non-mydriatic retinal camera.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Topcon Medical Systems, Inc.

Oakland, New Jersey, 07436, United States

About this study

Establish a normal baseline setting configuration for image capture using the Topcon TRC-NW400 non-mydriatic retinal camera. While also comparing the images to other manufacturer's retinal cameras

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects with no known ocular diseases

Exclusion criteria

  • Subjects with known ocular diseases

Treatment and study plan

Topcon TRC-NW400

Device

Retinal Fundus Camera

TRC-NW8

Device

Retinal Fundus Camera

TRC-NW400

Device

Retinal Fundus Camera

Canon-CR2

Device

Retinal Fundus Camera

Zeiss Visucam PRO

Device

Retinal Fundus Camera

Primary outcomes

  1. Fundus Image Grading

    Time frame: 1 Hour

    Determining the best display to reflect the real color of the retina

Sponsors and collaborators

Lead sponsor

Topcon Medical Systems, Inc.

Industry

Registry information

Official study title

TRC-NW400 Retinal Fundus Camera Image Evaluation and Instrument Comparison Protocol

Important dates

Study start
2014
Primary completion
2014
Study completion
2015
First posted
Nov 18, 2014
Registry last updated
Jun 8, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.